CEO01: Making Cell & Gene Therapy Accessible To All W/ The CEO of Orgenesis, Vered Caplan
Vered Caplan is the CEO of Orgenesis, a fast-growing company in the gene and cell industry. Known as a visionary, she elaborates on her idea of decentralised cleanrooms to improve patient affordability and accessibility for many therapies out there.
In addition, she also shares more about the growth potential and the competitive advantages of its business model.
For more information about Orgenesis, visit their website at https://ir.orgenesis.com/overview
Listen on to find out more!
00:01:07 -- Introduction of Vered Caplan
00:05:49 -- Orgenesis’ Value Proposition to the Cell and Gene Industry
00:11:42 -- How Vered Got Her Conviction for Decentralised Cleanrooms
00:20:16 -- How Decentralised Cleanrooms is More Profitable and Scalable
00:28:08 -- What is Orgenesis Mobile Processing Units and Labs (OMPUL)? 00:34:07 -- The Growth and Deployment of OMPULs
00:37:04 -- The People of Orgenesis
00:43:06 -- What is the “Moat” of Orgenesis?
00:50:12 -- How Orgenesis Manages Its Portfolio of Therapies
00:52:52 -- How Vered Views Her Portfolio of Therapies
00:56:23 -- Why the Financials of Orgenesis is Misunderstood
01:02:55 -- Her Personal Sacrifice
01:08:54 -- More about Orgenesis
Listen to My Podcast Here:
Apple Podcast: https://podcasts.apple.com/sg/podcast/growth-investing-secrets-podcast/id1475778230
Follow Kelvestor on Instagram:
Follow JangtheInvestor on Youtube: